• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 Hippo 通路促进心脏修复。

Targeting the Hippo pathway in heart repair.

机构信息

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Texas Heart Institute, 6770 Bertner Avenue, Houston, TX 77030, USA.

出版信息

Cardiovasc Res. 2022 Aug 24;118(11):2402-2414. doi: 10.1093/cvr/cvab291.

DOI:10.1093/cvr/cvab291
PMID:34528077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9400419/
Abstract

The Hippo pathway is an evolutionarily and functionally conserved signalling pathway that controls organ size by regulating cell proliferation, apoptosis, and differentiation. Emerging evidence has shown that the Hippo pathway plays critical roles in cardiac development, homeostasis, disease, and regeneration. Targeting the Hippo pathway has tremendous potential as a therapeutic strategy for treating intractable cardiovascular diseases, such as heart failure. In this review, we summarize the function of the Hippo pathway in the heart. Particularly, we highlight the post-translational modification of Hippo pathway components, including the core kinases LATS1/2 and their downstream effectors YAP/TAZ, in different contexts, which has provided new insights and avenues in cardiac research.

摘要

Hippo 通路是一条进化上和功能上保守的信号通路,通过调节细胞增殖、凋亡和分化来控制器官大小。新出现的证据表明,Hippo 通路在心脏发育、稳态、疾病和再生中发挥着关键作用。靶向 Hippo 通路作为治疗心力衰竭等难治性心血管疾病的治疗策略具有巨大的潜力。在这篇综述中,我们总结了 Hippo 通路在心脏中的功能。特别是,我们强调了 Hippo 通路成分的翻译后修饰,包括核心激酶 LATS1/2 及其下游效应物 YAP/TAZ,在不同的环境下,这为心脏研究提供了新的见解和途径。

相似文献

1
Targeting the Hippo pathway in heart repair.靶向 Hippo 通路促进心脏修复。
Cardiovasc Res. 2022 Aug 24;118(11):2402-2414. doi: 10.1093/cvr/cvab291.
2
The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.心脏中的 Hippo 通路:在发育、疾病和再生中的关键作用。
Nat Rev Cardiol. 2018 Nov;15(11):672-684. doi: 10.1038/s41569-018-0063-3.
3
The Hippo signaling pathway in liver regeneration and tumorigenesis.肝脏再生与肿瘤发生中的河马信号通路。
Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):46-52. doi: 10.1093/abbs/gmu106. Epub 2014 Dec 4.
4
MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.丝裂原活化蛋白激酶激酶激酶2(MEKK2)和丝裂原活化蛋白激酶激酶激酶3(MEKK3)协调多种信号以调节Hippo信号通路。
J Biol Chem. 2021 Jan-Jun;296:100400. doi: 10.1016/j.jbc.2021.100400. Epub 2021 Feb 9.
5
The Hippo pathway and its correlation with acute kidney injury.Hippo 通路及其与急性肾损伤的相关性。
Zool Res. 2022 Sep 18;43(5):897-910. doi: 10.24272/j.issn.2095-8137.2022.110.
6
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.鉴定 PTPN12 磷酸酶为乳腺癌 Hippo 通路效应物 YAP/TAZ 的新型负调控因子。
Int J Mol Sci. 2024 Apr 5;25(7):4064. doi: 10.3390/ijms25074064.
7
[Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms].[河马信号通路在胃肠道癌症中的新作用及其分子机制]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(1):35-43. doi: 10.3785/j.issn.1008-9292.2020.02.23.
8
The role of the Hippo pathway in heart disease.Hippo 通路在心脏病中的作用。
FEBS J. 2022 Oct;289(19):5819-5833. doi: 10.1111/febs.16092. Epub 2021 Jul 12.
9
Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.大肿瘤抑制同源物1和2通过拮抗共激活因子YAP和TAZ来调节小鼠肝祖细胞的增殖和成熟。
Hepatology. 2016 Nov;64(5):1757-1772. doi: 10.1002/hep.28768. Epub 2016 Sep 30.
10
Emerging role of Hippo pathway in the regulation of hematopoiesis.Hippo 通路在造血调控中的新兴作用。
BMB Rep. 2023 Aug;56(8):417-425. doi: 10.5483/BMBRep.2023-0094.

引用本文的文献

1
Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine.用于再生医学的LATS1和LATS2激酶抑制剂的发现与优化
J Med Chem. 2025 Aug 28;68(16):17499-17515. doi: 10.1021/acs.jmedchem.5c01027. Epub 2025 Aug 6.
2
Heart failure, inflammation and exercise.心力衰竭、炎症与运动
Int J Biol Sci. 2025 Apr 28;21(8):3324-3350. doi: 10.7150/ijbs.109917. eCollection 2025.
3
Targeting the Hippo Pathway for Cardiac Regeneration.靶向河马通路促进心脏再生
Physiology (Bethesda). 2025 Nov 1;40(6):0. doi: 10.1152/physiol.00003.2025. Epub 2025 May 13.
4
The effects of YAP/TAZ in cardiomyocytes: a scoping review.YAP/TAZ在心肌细胞中的作用:一项范围综述。
Mol Biol Rep. 2025 Apr 15;52(1):392. doi: 10.1007/s11033-025-10492-5.
5
Cardioprotective mechanism of Qixuan Yijianing formula in Graves' disease mice using miRNA sequencing approach.基于miRNA测序法探讨芪玄益甲宁方对Graves病小鼠的心脏保护机制
J Tradit Chin Med. 2024 Dec;44(6):1127-1136. doi: 10.19852/j.cnki.jtcm.20240927.005.
6
Force-sensing protein expression in response to cardiovascular mechanotransduction.响应心血管机械转导的力敏蛋白表达
EBioMedicine. 2024 Dec;110:105412. doi: 10.1016/j.ebiom.2024.105412. Epub 2024 Oct 30.
7
Untangling the role of RhoA in the heart: protective effect and mechanism.解析 RhoA 在心脏中的作用:保护作用及其机制。
Cell Death Dis. 2024 Aug 9;15(8):579. doi: 10.1038/s41419-024-06928-8.
8
Bone marrow mesenchymal stem cells-derived exosomal lncRNA GAS5 mitigates heart failure by inhibiting UL3/Hippo pathway-mediated ferroptosis.骨髓间充质干细胞来源的外泌体 lncRNA GAS5 通过抑制 UL3/Hippo 通路介导的铁死亡减轻心力衰竭。
Eur J Med Res. 2024 May 30;29(1):303. doi: 10.1186/s40001-024-01880-x.
9
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM.成纤维细胞通过细胞外基质协调心脏中的细胞间相互作用。
Nat Cardiovasc Res. 2022 Apr;1(4):312-321. doi: 10.1038/s44161-022-00043-7. Epub 2022 Apr 13.
10
HAX1-Overexpression Augments Cardioprotective Efficacy of Stem Cell-Based Therapy Through Mediating Hippo-Yap Signaling.HAX1 过表达通过介导 Hippo-Yap 信号增强基于干细胞的治疗的心脏保护作用。
Stem Cell Rev Rep. 2024 Aug;20(6):1569-1586. doi: 10.1007/s12015-024-10729-z. Epub 2024 May 7.

本文引用的文献

1
YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.YAP/TAZ 缺陷可重塑巨噬细胞表型,并改善心肌梗死后的梗死愈合及心脏功能。
PLoS Biol. 2020 Dec 2;18(12):e3000941. doi: 10.1371/journal.pbio.3000941. eCollection 2020 Dec.
2
Heat stress activates YAP/TAZ to induce the heat shock transcriptome.热应激激活 YAP/TAZ 诱导热休克转录组。
Nat Cell Biol. 2020 Dec;22(12):1447-1459. doi: 10.1038/s41556-020-00602-9. Epub 2020 Nov 16.
3
ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration.ERBB2 驱动心脏再生过程中的 YAP 激活和 EMT 样过程。
Nat Cell Biol. 2020 Nov;22(11):1346-1356. doi: 10.1038/s41556-020-00588-4. Epub 2020 Oct 12.
4
Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition.成纤维细胞YAP的阻断通过抑制MRTF-A减轻心脏纤维化和功能障碍。
JACC Basic Transl Sci. 2020 Sep 28;5(9):931-945. doi: 10.1016/j.jacbts.2020.07.009. eCollection 2020 Sep.
5
Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart.闰盘蛋白Xinβ是心脏中Hippo-YAP信号传导所必需的。
Nat Commun. 2020 Sep 16;11(1):4666. doi: 10.1038/s41467-020-18379-8.
6
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.E3 泛素连接酶 PARK2 调控 Hippo/YAP 信号通路及食管鳞癌的进展
Theranostics. 2020 Jul 25;10(21):9443-9457. doi: 10.7150/thno.46078. eCollection 2020.
7
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis.巨噬细胞 K63 连接泛素化 YAP 促进其核定位并加剧动脉粥样硬化。
Cell Rep. 2020 Aug 4;32(5):107990. doi: 10.1016/j.celrep.2020.107990.
8
gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration.gp130调控心肌细胞增殖与心脏再生。
Circulation. 2020 Sep 8;142(10):967-982. doi: 10.1161/CIRCULATIONAHA.119.044484. Epub 2020 Jun 30.
9
-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity.GlcNAcylation 作用于 LATS2,通过抑制其活性来破坏 Hippo 通路。
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14259-14269. doi: 10.1073/pnas.1913469117. Epub 2020 Jun 8.
10
Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation.人脐带间充质干细胞来源的外泌体通过 CK1δ/β-TRCP 介导的 YAP 降解减轻肾脏纤维化。
Cell Death Dis. 2020 May 7;11(5):327. doi: 10.1038/s41419-020-2510-4.